Delivery Order SPE2DR25D1004-SPE2DR26FSUT1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a contract value of $4,488.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on November 10, 2025, with a ceiling value of $3,161.23. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) at a ceiling value of $8,368.73. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award will be completed by October 28, 2025, reflecting the expedited nature of this medical supply procurement for federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,556.63 for Carvedilol ER 40 mg capsules (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,687.29. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $3,309.42 under firm fixed price terms. The order is scheduled for completion by September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,453.54 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Carvedilol ER 80 mg capsules (30-count unit) with a contract ceiling value of $1,389.87. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement and is scheduled for completion by October 30, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSUT1Delivery Order
The Defense Logistics Agency awarded a $4,146.89 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units). This is a firm fixed price delivery order with an ultimate completion date of November 12, 2025, reflecting the expedited nature of military pharmaceutical procurement. The contract was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. This prime pharmaceutical supply contract serves as a comprehensive global procurement vehicle enabling AmerisourceBergen to deliver a broad range of generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The current carvedilol delivery represents routine fulfillment of pharmaceutical requirements under this strategic medical supply agreement supporting federal military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/10/25 |